I build deep-tech ventures from founding concept to commercial launch. Twice I've taken novel microfluidic platforms from a lab bench to a manufactured product — building the R&D organizations, securing the funding, forging the partnerships, and navigating the pivots that turn breakthrough science into working businesses.At MicroMedicine, I joined as the first employee and founding team member, building on technology I invented at MGH. I built the R&D organization from scratch, led the development of the Sorterra™ cell processing platform, and drove the execution that secured $38M in milestone-based funding.At BendBio, I co-founded the company, invented core microfluidic IP, and engineered a capital-efficient business model that generated first revenues and preserved 100% founder equity through a partnership-funded model.My approach is first-principles and predictive — I'd rather kill a bad idea in simulation than burn cash proving it in the lab. I build teams of high-agency operators, give them real autonomy, and treat the business model as an engineering problem with the same rigor as the physics.Having built and stabilized these ventures, I am pursuing my next senior leadership challenge — as a CTO or VP R&D for a high-impact platform technology, or as an operating partner guiding a portfolio of deep-tech ventures. I am particularly focused on diagnostics, therapeutics, and the emerging intersection of AI and life sciences.

• View Full Profile on LinkedIn

Download Resume  • Contact via Email  • Explore Advisory Work